SEARCH

SEARCH BY CITATION

References

  • Alizadeh, A.A., Eisen, M.B., Davis, R.E., Ma, C., Lossos, I.S., Rosenwald, A., Boldrick, J.C., Sabet, H., Tran, T., Yu, X., Powell, J.I., Yang, L., Marti, G.E., Moore, T., Hudson, Jr, J., Lu, L., Lewis, D.B., Tibshirani, R., Sherlock, G., Chan, W.C., Greiner, T.C., Weisenburger, D.D., Armitage, J.O., Warnke, R., Levy, R., Wilson, W., Grever, M.R., Byrd, J.C., Botstein, D., Brown, P.O. & Staudt, L.M. (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature, 403, 503511.
  • Annunziata, C.M., Davis, R.E., Demchenko, Y., Bellamy, W., Gabrea, A., Zhan, F., Lenz, G., Hanamura, I., Wright, G., Xiao, W., Dave, S., Hurt, E.M., Tan, B., Zhao, H., Stephens, O., Santra, M., Williams, D.R., Dang, L., Barlogie, B., Shaughnessy, Jr, J.D., Kuehl, W.M. & Staudt, L.M. (2007) Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell, 12, 115130.
  • Avellino, R., Romano, S., Parasole, R., Bisogni, R., Lamberti, A., Poggi, V., Venuta, S. & Romano, M.F. (2005) Rapamycin stimulates apoptosis of childhood acute lymphoblastic leukemia cells. Blood, 106, 14001406.
  • Bargou, R.C., Emmerich, F., Krappmann, D., Bommert, K., Mapara, M.Y., Arnold, W., Royer, H.D., Grinstein, E., Greiner, A., Scheidereit, C. & Dorken, B. (1997) Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin’s disease tumor cells. Journal of Clinical Investigation, 100, 29612969.
  • Barth, T.F., Martin-Subero, J.I., Joos, S., Menz, C.K., Hasel, C., Mechtersheimer, G., Parwaresch, R.M., Lichter, P., Siebert, R. & Mooller, P. (2003) Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma. Blood, 101, 36813686.
  • Bernal-Mizrachi, L., Lovly, C.M. & Ratner, L. (2006) The role of NF-{kappa}B-1 and NF-{kappa}B-2-mediated resistance to apoptosis in lymphomas. Proceedings of the National Academy of Sciences of the United States of America, 103, 92209225.
  • Bharti, A.C., Donato, N., Singh, S. & Aggarwal, B.B. (2003) Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood, 101, 10531062.
  • Cabannes, E., Khan, G., Aillet, F., Jarrett, R.F. & Hay, R.T. (1999) Mutations in the IkBa gene in Hodgkin’s disease suggest a tumour suppressor role for IkappaBalpha. Oncogene, 18, 30633070.
  • Cahir-McFarland, E.D., Davidson, D.M., Schauer, S.L., Duong, J. & Kieff, E. (2000) NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells. Proceedings of the National Academy of Sciences of the United States of America, 97, 60556060.
  • Campbell, K.J., Rocha, S. & Perkins, N.D. (2004) Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B. Molecular Cell, 13, 853865.
  • Carter, R.S., Geyer, B.C., Xie, M., Acevedo-Suarez, C.A. & Ballard, D.W. (2001) Persistent activation of NF-kappa B by the tax transforming protein involves chronic phosphorylation of IkappaB kinase subunits IKKbeta and IKKgamma. Journal of Biological Chemistry, 276, 2444524448.
  • Courtois, G. & Gilmore, T.D. (2006) Mutations in the NF-kappaB signaling pathway: implications for human disease. Oncogene, 25, 68316843.
  • Cuni, S., Perez-Aciego, P., Perez-Chacon, G., Vargas, J.A., Sanchez, A., Martin-Saavedra, F.M., Ballester, S., Garcia-Marco, J., Jorda, J. & Durantez, A. (2004) A sustained activation of PI3K/NF-kappaB pathway is critical for the survival of chronic lymphocytic leukemia B cells. Leukemia, 18, 13911400.
  • D’Acquisto, F. & Ianaro, A. (2006) From willow bark to peptides: the ever widening spectrum of NF-kappaB inhibitors. Current Opinion in Pharmacology, 6, 387392.
  • Dai, Y., Chen, S., Kramer, L.B., Funk, V.L., Dent, P. & Grant, S. (2008) Interactions between bortezomib and romidepsin and belinostat in chronic lymphocytic leukemia cells. Clinical Cancer Research, 14, 549558.
  • Davis, R.E., Brown, K.D., Siebenlist, U. & Staudt, L.M. (2001) Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. Journal of Experimental Medicine, 194, 18611874.
  • Dutton, A., Woodman, C.B., Chukwuma, M.B., Last, J.I., Wei, W., Vockerodt, M., Baumforth, K.R., Flavell, J.R., Rowe, M., Taylor, A.M., Young, L.S. & Murray, P.G. (2007) Bmi-1 is induced by the Epstein–Barr virus oncogene LMP1 and regulates the expression of viral target genes in Hodgkin lymphoma cells. Blood, 109, 25972603.
  • Ehrhardt, H., Fulda, S., Schmid, I., Hiscott, J., Debatin, K.M. & Jeremias, I. (2003) TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-kappaB. Oncogene, 22, 38423852.
  • Emmerich, F., Meiser, M., Hummel, M., Demel, G., Foss, H.D., Jundt, F., Mathas, S., Krappmann, D., Scheidereit, C., Stein, H. & Dorken, B. (1999) Overexpression of I kappa B alpha without inhibition of NF-kappaB activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells. Blood, 94, 31293134.
  • Emmerich, F., Theurich, S., Hummel, M., Haeffker, A., Vry, M.S., Dohner, K., Bommert, K., Stein, H. & Dorken, B. (2003) Inactivating I kappa B epsilon mutations in Hodgkin/Reed-Sternberg cells. Journal of Pathology, 201, 413420.
  • Endo, T., Nishio, M., Enzler, T., Cottam, H.B., Fukuda, T., James, D.F., Karin, M. & Kipps, T.J. (2007) BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway. Blood, 109, 703710.
  • Feuerhake, F., Kutok, J.L., Monti, S., Chen, W., LaCasce, A.S., Cattoretti, G., Kurtin, P., Pinkus, G.S., De Leval, L., Harris, N.L., Savage, K.J., Neuberg, D., Habermann, T.M., Dalla-Favera, R., Golub, T.R., Aster, J.C. & Shipp, M.A. (2005) NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes. Blood, 106, 13921399.
  • Fiumara, P., Snell, V., Li, Y., Mukhopadhyay, A., Younes, M., Gillenwater, A.M., Cabanillas, F., Aggarwal, B.B. & Younes, A. (2001) Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines. Blood, 98, 27842790.
  • Garcia-Pineres, A.J., Castro, V., Mora, G., Schmidt, T.J., Strunck, E., Pahl, H.L. & Merfort, I. (2001) Cysteine 38 in p65/NF-kappaB plays a crucial role in DNA binding inhibition by sesquiterpene lactones. Journal of Biological Chemistry, 276, 3971339720.
  • Gilmore, T.D. (2006) Introduction to NF-kappaB: players, pathways, perspectives. Oncogene, 25, 66806684.
  • Gilmore, T.D. (2007) Multiple myeloma: lusting for NF-kappaB. Cancer Cell, 12, 9597.
  • Gilmore, T.D. & Herscovitch, M. (2006) Inhibitors of NF-kappaB signaling: 785 and counting. Oncogene, 25, 68876899.
  • Gilmore, T.D., Kalaitzidis, D., Liang, M.C. & Starczynowski, D.T. (2004) The c-Rel transcription factor and B-cell proliferation: a deal with the devil. Oncogene, 23, 22752286.
  • Guasparri, I., Bubman, D. & Cesarman, E. (2008) EBV LMP2A affects LMP1-mediated NF-{kappa}B signaling and survival of lymphoma cells by regulating TRAF2 expression. Blood, 111, 38133820.
  • Hacker, H. & Karin, M. (2006) Regulation and function of IKK and IKK-related kinases. Science’s STKE, 2006, re13.
  • Hasegawa, H., Sawa, H., Lewis, M.J., Orba, Y., Sheehy, N., Yamamoto, Y., Ichinohe, T., Tsunetsugu-Yokota, Y., Katano, H., Takahashi, H., Matsuda, J., Sata, T., Kurata, T., Nagashima, K. & Hall, W.W. (2006) Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I. Nature Medicine, 12, 466472.
  • Hewamana, S., Alghazal, S., Lin, T.T., Clement, M., Jenkins, C., Guzman, M.L., Jordan, C.T., Neelakantan, S., Crooks, P.A., Burnett, A.K., Pratt, G., Fegan, C., Rowntree, C., Brennan, P. & Pepper, C. (2008) The NF-{kappa}B subunit, Rel A, is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukaemia and represents a promising therapeutic target. Blood, 111, 46814689.
  • Hideshima, T., Neri, P., Tassone, P., Yasui, H., Ishitsuka, K., Raje, N., Chauhan, D., Podar, K., Mitsiades, C., Dang, L., Munshi, N., Richardson, P., Schenkein, D. & Anderson, K.C. (2006) MLN120B, a novel IkappaB kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivo. Clinical Cancer Research, 12, 58875894.
  • Hideshima, T., Mitsiades, C., Tonon, G., Richardson, P.G. & Anderson, K.C. (2007) Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets. Nature Reviews. Cancer, 7, 585598.
  • Hinz, M., Lemke, P., Anagnostopoulos, I., Hacker, C., Krappmann, D., Mathas, S., Dorken, B., Zenke, M., Stein, H. & Scheidereit, C. (2002) Nuclear factor kappaB-dependent gene expression profiling of Hodgkin’s disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity. Journal of Experimental Medicine, 196, 605617.
  • Hoffmann, A., Natoli, G. & Ghosh, G. (2006) Transcriptional regulation via the NF-kappaB signaling module. Oncogene, 25, 67066716.
  • Horie, R., Watanabe, T., Ito, K., Morisita, Y., Watanabe, M., Ishida, T., Higashihara, M. & Kadin, M. (2002) Cytoplasmic aggregation of TRAF2 and TRAF5 proteins in the Hodgkin-Reed-Sternberg cells. American Journal of Pathology, 160, 16471654.
  • Houldsworth, J., Olshen, A.B., Cattoretti, G., Donnelly, G.B., Teruya-Feldstein, J., Qin, J., Palanisamy, N., Shen, Y., Dyomina, K., Petlakh, M., Pan, Q., Zelenetz, A.D., Dalla-Favera, R. & Chaganti, R.S. (2004) Relationship between REL amplification, REL function, and clinical and biologic features in diffuse large B-cell lymphomas. Blood, 103, 18621868.
  • Hunt, K.E. & Reichard, K.K. (2008) Diffuse large B-cell lymphoma. Archives of Pathology and Laboratory Medicine, 132, 118124.
  • Ishikawa, H., Carrasco, D., Claudio, E., Ryseck, R.P. & Bravo, R. (1997) Gastric hyperplasia and increased proliferative responses of lymphocytes in mice lacking the COOH-terminal ankyrin domain of NF-kappaB2. Journal of Experimental Medicine, 186, 9991014.
  • Izban, K.F., Ergin, M., Qin, J.Z., Martinez, R.L., Pooley, R.J., Saeed, S. & Alkan, S. (2000) Constitutive expression of NF-kappa B is a characteristic feature of mycosis fungoides: implications for apoptosis resistance and pathogenesis. Human Pathology, 31, 14821490.
  • Izban, K.F., Ergin, M., Huang, Q., Qin, J.Z., Martinez, R.L., Schnitzer, B., Ni, H., Nickoloff, B.J. & Alkan, S. (2001) Characterization of NF-kappaB expression in Hodgkin’s disease: inhibition of constitutively expressed NF-kappaB results in spontaneous caspase-independent apoptosis in Hodgkin and Reed-Sternberg cells. Modern Pathology, 14, 297310.
  • Jazirehi, A.R., Huerta-Yepez, S., Cheng, G. & Bonavida, B. (2005) Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa}B signaling pathway in non-Hodgkin’s lymphoma B-cell lines: role in sensitization to chemotherapeutic drug-induced apoptosis. Cancer Research, 65, 264276.
  • Jost, P.J. & Ruland, J. (2007) Aberrant NF-kappaB signaling in lymphoma: mechanisms, consequences, and therapeutic implications. Blood, 109, 27002707.
  • Jourdan, M., Moreaux, J., Vos, J.D., Hose, D., Mahtouk, K., Abouladze, M., Robert, N., Baudard, M., Reme, T., Romanelli, A., Goldschmidt, H., Rossi, J.F., Dreano, M. & Klein, B. (2007) Targeting NF-kappaB pathway with an IKK2 inhibitor induces inhibition of multiple myeloma cell growth. British Journal of Haematology, 138, 160168.
  • Jungnickel, B., Staratschek-Jox, A., Brauninger, A., Spieker, T., Wolf, J., Diehl, V., Hansmann, M.L., Rajewsky, K. & Kuppers, R. (2000) Clonal deleterious mutations in the IkappaBalpha gene in the malignant cells in Hodgkin’s lymphoma. Journal of Experimental Medicine, 191, 395402.
  • Karin, M., Yamamoto, Y. & Wang, Q.M. (2004) The IKK NF-kappa B system: a treasure trove for drug development. Nature Reviews. Drug Discovery, 3, 1726.
  • Kashkar, H., Deggerich, A., Seeger, J.M., Yazdanpanah, B., Wiegmann, K., Haubert, D., Pongratz, C. & Kronke, M. (2007) NF-kappaB-independent down-regulation of XIAP by bortezomib sensitizes HL B cells against cytotoxic drugs. Blood, 109, 39823988.
  • Keats, J.J., Fonseca, R., Chesi, M., Schop, R., Baker, A., Chng, W.J., Van Wier, S., Tiedemann, R., Shi, C.X., Sebag, M., Braggio, E., Henry, T., Zhu, Y.X., Fogle, H., Price-Troska, T., Ahmann, G., Mancini, C., Brents, L.A., Kumar, S., Greipp, P., Dispenzieri, A., Bryant, B., Mulligan, G., Bruhn, L., Barrett, M., Valdez, R., Trent, J., Stewart, A.K., Carpten, J. & Bergsagel, P.L. (2007) Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. Cancer Cell, 12, 131144.
  • Keifer, J.A., Guttridge, D.C., Ashburner, B.P. & Baldwin, Jr, A.S. (2001) Inhibition of NF-kappa B activity by thalidomide through suppression of IkappaB kinase activity. Journal of Biological Chemistry, 276, 2238222387.
  • Keller, S.A., Schattner, E.J. & Cesarman, E. (2000) Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells. Blood, 96, 25372542.
  • Kim, E.J., Hess, S., Richardson, S.K., Newton, S., Showe, L.C., Benoit, B.M., Ubriani, R., Vittorio, C.C., Junkins-Hopkins, J.M., Wysocka, M. & Rook, A.H. (2005) Immunopathogenesis and therapy of cutaneous T cell lymphoma. Journal of Clinical Investigation, 115, 798812.
  • Kim, S.W., Oleksyn, D.W., Rossi, R.M., Jordan, C.T., Sanz, I., Chen, L. & Zhao, J. (2008) Protein kinase C-associated kinase is required for NF-{kappa}B signaling and survival in diffuse large B-cell lymphoma cells. Blood, 111, 16441653.
  • Kordes, U., Krappmann, D., Heissmeyer, V., Ludwig, W.D. & Scheidereit, C. (2000) Transcription factor NF-kappaB is constitutively activated in acute lymphoblastic leukemia cells. Leukemia, 14, 399402.
  • Kuo, S.H., Chen, L.T., Yeh, K.H., Wu, M.S., Hsu, H.C., Yeh, P.Y., Mao, T.L., Chen, C.L., Doong, S.L., Lin, J.T. & Cheng, A.L. (2004) Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas. Journal of Clinical Oncology, 22, 34913497.
  • Lam, L.T., Davis, R.E., Pierce, J., Hepperle, M., Xu, Y., Hottelet, M., Nong, Y., Wen, D., Adams, J., Dang, L. & Staudt, L.M. (2005) Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling. Clinical Cancer Research, 11, 2840.
  • Liang, M.C., Bardhan, S., Li, C., Pace, E.A., Porco, Jr, J.A. & Gilmore, T.D. (2003) Jesterone dimer, a synthetic derivative of the fungal metabolite jesterone, blocks activation of transcription factor nuclear factor kappaB by inhibiting the inhibitor of kappaB kinase. Molecular Pharmacology, 64, 123131.
  • Liu, L., Eby, M.T., Rathore, N., Sinha, S.K., Kumar, A. & Chaudhary, P.M. (2002) The human herpes virus 8-encoded viral FLICE inhibitory protein physically associates with and persistently activates the Ikappa B kinase complex. Journal of Biological Chemistry, 277, 1374513751.
  • Martinez, N., Camacho, F.I., Algara, P., Rodriguez, A., Dopazo, A., Ruiz-Ballesteros, E., Martin, P., Martinez-Climent, J.A., Garcia-Conde, J., Menarguez, J., Solano, F., Mollejo, M. & Piris, M.A. (2003) The molecular signature of mantle cell lymphoma reveals multiple signals favoring cell survival. Cancer Research, 63, 82268232.
  • Mathas, S., Lietz, A., Janz, M., Hinz, M., Jundt, F., Scheidereit, C., Bommert, K. & Dorken, B. (2003) Inhibition of NF-kappaB essentially contributes to arsenic-induced apoptosis. Blood, 102, 10281034.
  • Mathas, S., Lietz, A., Anagnostopoulos, I., Hummel, F., Wiesner, B., Janz, M., Jundt, F., Hirsch, B., Johrens-Leder, K., Vornlocher, H.P., Bommert, K., Stein, H. & Dorken, B. (2004) c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis. Journal of Experimental Medicine, 199, 10411052.
  • Matta, H. & Chaudhary, P.M. (2004) Activation of alternative NF-kappa B pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1 beta-converting enzyme inhibitory protein (vFLIP). Proceedings of the National Academy of Sciences of the United States of America, 101, 93999404.
  • Migliazza, A., Lombardi, L., Rocchi, M., Trecca, D., Chang, C.C., Antonacci, R., Fracchiolla, N.S., Ciana, P., Maiolo, A.T. & Neri, A. (1994) Heterogeneous chromosomal aberrations generate 3′ truncations of the NFKB2/lyt-10 gene in lymphoid malignancies. Blood, 84, 38503860.
  • Mitsiades, N., Mitsiades, C.S., Poulaki, V., Chauhan, D., Richardson, P.G., Hideshima, T., Munshi, N.C., Treon, S.P. & Anderson, K.C. (2002) Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications. Blood, 99, 45254530.
  • Monti, S., Savage, K.J., Kutok, J.L., Feuerhake, F., Kurtin, P., Mihm, M., Wu, B., Pasqualucci, L., Neuberg, D., Aguiar, R.C., Dal Cin, P., Ladd, C., Pinkus, G.S., Salles, G., Harris, N.L., Dalla-Favera, R., Habermann, T.M., Aster, J.C., Golub, T.R. & Shipp, M.A. (2005) Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood, 105, 18511861.
  • Mori, N., Yamada, Y., Ikeda, S., Yamasaki, Y., Tsukasaki, K., Tanaka, Y., Tomonaga, M., Yamamoto, N. & Fujii, M. (2002) Bay 11-7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells. Blood, 100, 18281834.
  • Munzert, G., Kirchner, D., Ottmann, O., Bergmann, L. & Schmid, R.M. (2004) Constitutive NF-kappab/Rel activation in Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL). Leukaemia & Lymphoma, 45, 11811184.
  • Natoli, G., Saccani, S., Bosisio, D. & Marazzi, I. (2005) Interactions of NF-kappaB with chromatin: the art of being at the right place at the right time. Nature Immunology, 6, 439445.
  • Nencioni, A., Grunebach, F., Patrone, F., Ballestrero, A. & Brossart, P. (2007) Proteasome inhibitors: antitumor effects and beyond. Leukemia, 21, 3036.
  • Neri, A., Fracchiolla, N.S., Migliazza, A., Trecca, D. & Lombardi, L. (1996) The involvement of the candidate proto-oncogene NFKB2/lyt-10 in lymphoid malignancies. Leukaemia & Lymphoma, 23, 4348.
  • Ngo, V.N., Davis, R.E., Lamy, L., Yu, X., Zhao, H., Lenz, G., Lam, L.T., Dave, S., Yang, L., Powell, J. & Staudt, L.M. (2006) A loss-of-function RNA interference screen for molecular targets in cancer. Nature, 441, 106110.
  • Ni, H., Ergin, M., Huang, Q., Qin, J.Z., Amin, H.M., Martinez, R.L., Saeed, S., Barton, K. & Alkan, S. (2001) Analysis of expression of nuclear factor kappa B (NF-kappa B) in multiple myeloma: downregulation of NF-kappa B induces apoptosis. British Journal of Haematology, 115, 279286.
  • O’Connell, M.A., Cleere, R., Long, A., O’Neill, L.A. & Kelleher, D. (1995) Cellular proliferation and activation of NF kappa B are induced by autocrine production of tumor necrosis factor alpha in the human T lymphoma line HuT 78. Journal of Biological Chemistry, 270, 73997404.
  • O’Neil, J., Calvo, J., McKenna, K., Krishnamoorthy, V., Aster, J.C., Bassing, C.H., Alt, F.W., Kelliher, M. & Look, A.T. (2006) Activating Notch1 mutations in mouse models of T-ALL. Blood, 107, 781785.
  • Ohmae, T., Hirata, Y., Maeda, S., Shibata, W., Yanai, A., Ogura, K., Yoshida, H., Kawabe, T. & Omata, M. (2005) Helicobacter pylori activates NF-kappaB via the alternative pathway in B lymphocytes. Journal of Immunology, 175, 71627169.
  • Olivier, S., Robe, P. & Bours, V. (2006) Can NF-kappaB be a target for novel and efficient anti-cancer agents? Biochemical Pharmacology, 72, 10541068.
  • Packham, G. & Stevenson, F.K. (2005) Bodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukaemia. Immunology, 114, 441449.
  • Perkins, N.D. (2006) Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway. Oncogene, 25, 67176730.
  • Pham, L.V., Tamayo, A.T., Yoshimura, L.C., Lo, P. & Ford, R.J. (2003) Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis. Journal of Immunology, 171, 8895.
  • Pickering, B.M., De Mel, S., Lee, M., Howell, M., Habens, F., Dallman, C.L., Neville, L.A., Potter, K.N., Mann, J., Mann, D.A., Johnson, P.W., Stevenson, F.K. & Packham, G. (2007) Pharmacological inhibitors of NF-kappaB accelerate apoptosis in chronic lymphocytic leukaemia cells. Oncogene, 26, 11661177.
  • Rayet, B. & Gelinas, C. (1999) Aberrant rel/nfkb genes and activity in human cancer. Oncogene, 18, 69386947.
  • Romano, M.F., Lamberti, A., Tassone, P., Alfinito, F., Costantini, S., Chiurazzi, F., Defrance, T., Bonelli, P., Tuccillo, F., Turco, M.C. & Venuta, S. (1998) Triggering of CD40 antigen inhibits fludarabine-induced apoptosis in B chronic lymphocytic leukemia cells. Blood, 92, 990995.
  • Rosenwald, A., Wright, G., Chan, W.C., Connors, J.M., Campo, E., Fisher, R.I., Gascoyne, R.D., Muller-Hermelink, H.K., Smeland, E.B., Giltnane, J.M., Hurt, E.M., Zhao, H., Averett, L., Yang, L., Wilson, W.H., Jaffe, E.S., Simon, R., Klausner, R.D., Powell, J., Duffey, P.L., Longo, D.L., Greiner, T.C., Weisenburger, D.D., Sanger, W.G., Dave, B.J., Lynch, J.C., Vose, J., Armitage, J.O., Montserrat, E., Lopez-Guillermo, A., Grogan, T.M., Miller, T.P., LeBlanc, M., Ott, G., Kvaloy, S., Delabie, J., Holte, H., Krajci, P., Stokke, T. & Staudt, L.M. (2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. New England Journal of Medicine, 346, 19371947.
  • Rosenwald, A., Wright, G., Leroy, K., Yu, X., Gaulard, P., Gascoyne, R.D., Chan, W.C., Zhao, T., Haioun, C., Greiner, T.C., Weisenburger, D.D., Lynch, J.C., Vose, J., Armitage, J.O., Smeland, E.B., Kvaloy, S., Holte, H., Delabie, J., Campo, E., Montserrat, E., Lopez-Guillermo, A., Ott, G., Muller-Hermelink, H.K., Connors, J.M., Braziel, R., Grogan, T.M., Fisher, R.I., Miller, T.P., LeBlanc, M., Chiorazzi, M., Zhao, H., Yang, L., Powell, J., Wilson, W.H., Jaffe, E.S., Simon, R., Klausner, R.D. & Staudt, L.M. (2003) Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. Journal of Experimental Medicine, 198, 851862.
  • Roue, G., Perez-Galan, P., Lopez-Guerra, M., Villamor, N., Campo, E. & Colomer, D. (2007) Selective inhibition of IkappaB kinase sensitizes mantle cell lymphoma B cells to TRAIL by decreasing cellular FLIP level. Journal of Immunology, 178, 19231930.
  • Rudelius, M., Pittaluga, S., Nishizuka, S., Pham, T.H., Fend, F., Jaffe, E.S., Quintanilla-Martinez, L. & Raffeld, M. (2006) Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma. Blood, 108, 16681676.
  • Soni, V., Cahir-McFarland, E. & Kieff, E. (2007) LMP1 TRAFficking activates growth and survival pathways. Advances in Experimental Medicine and Biology, 597, 173187.
  • Sors, A., Jean-Louis, F., Pellet, C., Laroche, L., Dubertret, L., Courtois, G., Bachelez, H. & Michel, L. (2006) Down-regulating constitutive activation of the NF-kappaB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis. Blood, 107, 23542363.
  • Starczynowski, D.T., Trautmann, H., Pott, C., Harder, L., Arnold, N., Africa, J.A., Leeman, J.R., Siebert, R. & Gilmore, T.D. (2007) Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL’s in vitro transforming activity. Oncogene, 26, 26852694.
  • Thakur, S., Lin, H.C., Tseng, W.T., Kumar, S., Bravo, R., Foss, F., Gelinas, C. & Rabson, A.B. (1994) Rearrangement and altered expression of the NFKB-2 gene in human cutaneous T-lymphoma cells. Oncogene, 9, 23352344.
  • Thomas, R.K., Re, D., Wolf, J. & Diehl, V. (2004) Part I: Hodgkin’s lymphoma–molecular biology of Hodgkin and Reed-Sternberg cells. The Lancet Oncology, 5, 1118.
  • Tissing, W.J., Den Boer, M.L., Meijerink, J.P., Menezes, R.X., Swagemakers, S., Van Der Spek, P.J., Sallan, S.E., Armstrong, S.A. & Pieters, R. (2007) Genomewide identification of prednisolone-responsive genes in acute lymphoblastic leukemia cells. Blood, 109, 39293935.
  • Vilimas, T., Mascarenhas, J., Palomero, T., Mandal, M., Buonamici, S., Meng, F., Thompson, B., Spaulding, C., Macaroun, S., Alegre, M.L., Kee, B.L., Ferrando, A., Miele, L. & Aifantis, I. (2007) Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemia. Nature Medicine, 13, 7077.
  • Watanabe, M., Dewan, M.Z., Taira, M., Shoda, M., Honda, M., Sata, T., Higashihara, M., Kadin, M.E., Watanabe, T., Yamamoto, N., Umezawa, K. & Horie, R. (2007) IkappaBalpha independent induction of NF-kappaB and its inhibition by DHMEQ in Hodgkin/Reed-Sternberg cells. Laboratory Investigation, 87, 372382.
  • Weng, A.P., Ferrando, A.A., Lee, W., Morris, J.P.T., Silverman, L.B., Sanchez-Irizarry, C., Blacklow, S.C., Look, A.T. & Aster, J.C. (2004) Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science, 306, 269271.
  • Xiao, G., Cvijic, M.E., Fong, A., Harhaj, E.W., Uhlik, M.T., Waterfield, M. & Sun, S.C. (2001) Retroviral oncoprotein Tax induces processing of NF-kappaB2/p100 in T cells: evidence for the involvement of IKKalpha. EMBO Journal, 20, 68056815.
  • Yeh, K.H., Kuo, S.H., Chen, L.T., Mao, T.L., Doong, S.L., Wu, M.S., Hsu, H.C., Tzeng, Y.S., Chen, C.L., Lin, J.T. & Cheng, A.L. (2005) Nuclear expression of BCL10 or nuclear factor kappa B helps predict Helicobacter pylori-independent status of low-grade gastric mucosa-associated lymphoid tissue lymphomas with or without t(11;18)(q21;q21). Blood, 106, 10371041.
  • Zhou, H., Du, M.Q. & Dixit, V.M. (2005) Constitutive NF-kappaB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity. Cancer Cell, 7, 425431.